Video

Aaron Lyss Outlines Lessons Learned From Data Analytics

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

Transcript:

Looking ahead, what are the unmet needs for the practice that could be assisted through a change in government policy?

I think the most critical aspect of government policy that can be addressed through alternative payment models is the payment schema supporting the transition from the fee-for-service environment to the value-based payment environment.

How do you use any lessons learned from data analytics to make any pivots or shifts in strategy?

I think in each performance period of the model for which we've received data, we've seen different aspects of care delivery that we can improve and focus on for the following 6 months. In several instances, this has had to do with the populations of patients in the specific types of cancers that we see in our data as opportunities to improve care delivery.

Related Videos
Kimberly Westrich, MA, chief strategy officer, NPC
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo